Anti-Ovarian Cancer Compound Library

Description: - A unique collection of 1867 compounds with anti-ovarian cancer therapeutic activity, can be used for anti-ovarian cancer drug discovery and pharmacological study;- Targets include PARP, VEGF, PD-1, HER2, etc;- Some compounds have already been launched or are in clinical phases.- Detailed compound information on structures, targets, IC50 and activity descriptions.- NMR and HPLC/LCMS validated to ensure high purity and quality.

• SKU: TGML2196-250uL
• Manufacturer: TargetMol Chemicals
• Manufacturer SKU: L2196-250uL
• Package Unit: 250 μL
• Quantity Unit: STK